Founded in 2018 by Dr. David Rallis, the Nebraska-based platform operates over 170 facilities and employs more than 220 surgeons. The transition marks a strategic pivot for the company, which aims to preserve its surgeon-first culture while leveraging the financial backing of the Warburg Pincus Capital Solutions Founders Fund. For the private equity firms involved, the deal represents an entry into a specialized, high-growth niche of the healthcare market.

Dr. Rallis noted that the partnership validates the company's existing clinical model and provides the necessary resources to scale operations. Adam Krainson and José Arredondo of Warburg Pincus emphasized that the investment targets businesses with established clinical foundations and clear potential for long-term growth. Financial terms of the transaction were not disclosed, though the move signals a wider trend of private equity firms favoring surgeon-led management teams to drive efficiency and patient outcomes.